Difficulty: Medium
Average Score: 69%
Practice
In the emergency department, the preferred first-line therapy for asthma exacerbation is
Correct answer
B
Rationale
In the context of managing asthma exacerbations in the emergency department, the preferred first-line therapy is a ╬▓-agonist, making option B the correct answer. ╬▓-agonists, such as albuterol, work rapidly to dilate bronchial smooth muscle, providing quick relief of bronchoconstriction and improving airflow. This is crucial during an acute asthma attack to alleviate symptoms and prevent respiratory distress.
Option A, Theophylline, is not the preferred first-line therapy for acute asthma exacerbations due to its slower onset of action compared to ╬▓-agonists. Using Theophylline in this scenario may delay symptom relief and exacerbate the patient's condition.
Corticosteroids, as in option C, play a crucial role in managing asthma by reducing airway inflammation. However, they are typically used as an adjunct therapy in the acute setting and are not as effective as ╬▓-agonists for rapid bronchodilation.
Cromolyn sodium, listed in option D, is an anti-inflammatory agent that is more commonly used for the prevention of asthma symptoms rather than for acute exacerbations. It is not the preferred first-line therapy for managing acute asthma attacks in the emergency department.
Educationally, understanding the rationale behind using ╬▓-agonists as the preferred initial treatment for asthma exacerbations helps healthcare professionals prioritize interventions based on evidence-based practices. This knowledge ensures timely and appropriate management of acute respiratory distress, ultimately improving patient outcomes and safety.
Option A, Theophylline, is not the preferred first-line therapy for acute asthma exacerbations due to its slower onset of action compared to ╬▓-agonists. Using Theophylline in this scenario may delay symptom relief and exacerbate the patient's condition.
Corticosteroids, as in option C, play a crucial role in managing asthma by reducing airway inflammation. However, they are typically used as an adjunct therapy in the acute setting and are not as effective as ╬▓-agonists for rapid bronchodilation.
Cromolyn sodium, listed in option D, is an anti-inflammatory agent that is more commonly used for the prevention of asthma symptoms rather than for acute exacerbations. It is not the preferred first-line therapy for managing acute asthma attacks in the emergency department.
Educationally, understanding the rationale behind using ╬▓-agonists as the preferred initial treatment for asthma exacerbations helps healthcare professionals prioritize interventions based on evidence-based practices. This knowledge ensures timely and appropriate management of acute respiratory distress, ultimately improving patient outcomes and safety.